Aripiprazole Therapy for manic episodes in bipolarity type I
This study is completed in France, in Austria, in Czechia, .... It is testing aripiprazole Therapy for manic episodes in bipolarity type I.
BipolarityDrugOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateJune 2008
Recruitment status
Completed
Enrollment listed in the registry
493
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
France, Austria, Czechia, ...
Age range
Over 18 Years
Official registry ID
NCT00665366
Official title
A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolar I Disorder Patients Treated on Valproate or Lithium and in Need of Further Clinical Improvement
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00665366. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Austria · 2 sites
Local Institution
Salzburg
Site status: Not listed — confirm with the team
Local Institution
Vienna
Site status: Not listed — confirm with the team
Czechia · 5 sites
Local Institution
Hradec Králové
Site status: Not listed — confirm with the team
Local Institution
Litoměřice
Site status: Not listed — confirm with the team
Local Institution
Prague
Site status: Not listed — confirm with the team
Local Institution
Prague
Site status: Not listed — confirm with the team
Local Institution
Prague
Site status: Not listed — confirm with the team
France · 15 sites
Local Institution
Beaupuy
Site status: Not listed — confirm with the team
Local Institution
Brumath
Site status: Not listed — confirm with the team
Local Institution
Château-Gontier
Site status: Not listed — confirm with the team
Local Institution
Clermont-Ferrand
Site status: Not listed — confirm with the team
Local Institution
Dijon
Site status: Not listed — confirm with the team
Local Institution
Dole
Site status: Not listed — confirm with the team
Local Institution
Jonzac
Site status: Not listed — confirm with the team
Local Institution
Le Vésinet
Site status: Not listed — confirm with the team
Local Institution
Montpellier
Site status: Not listed — confirm with the team
Local Institution
Nîmes
Site status: Not listed — confirm with the team
Local Institution
Paris
Site status: Not listed — confirm with the team
Local Institution
Reims
Site status: Not listed — confirm with the team
Local Institution
Saint-Nazaire
Site status: Not listed — confirm with the team
Local Institution
Sotteville-lès-Rouen
Site status: Not listed — confirm with the team
Local Institution
Strasbourg
Site status: Not listed — confirm with the team
Germany · 2 sites
Local Institution
Ellwangen
Site status: Not listed — confirm with the team
Local Institution
Ostfildern
Site status: Not listed — confirm with the team
Greece · 4 sites
Local Institution
Athens
Site status: Not listed — confirm with the team
Local Institution
Leros
Site status: Not listed — confirm with the team
Local Institution
Nea Ionia-Athens
Site status: Not listed — confirm with the team
Local Institution
Tripoli
Site status: Not listed — confirm with the team
Hungary · 6 sites
Local Institution
Budapest
Site status: Not listed — confirm with the team
Local Institution
Budapest
Site status: Not listed — confirm with the team
Local Institution
Budapest
Site status: Not listed — confirm with the team
Local Institution
Budapest
Site status: Not listed — confirm with the team
Local Institution
Győr
Site status: Not listed — confirm with the team
Local Institution
Gyula
Site status: Not listed — confirm with the team
Italy · 11 sites
Local Institution
Campobasso
Site status: Not listed — confirm with the team
Local Institution
Foggia
Site status: Not listed — confirm with the team
Local Institution
Foligno (Pg)
Site status: Not listed — confirm with the team
Local Institution
Genova
Site status: Not listed — confirm with the team
Local Institution
La Spezia
Site status: Not listed — confirm with the team
Local Institution
Milan
Site status: Not listed — confirm with the team
Local Institution
Naples
Site status: Not listed — confirm with the team
Local Institution
Pisa
Site status: Not listed — confirm with the team
Local Institution
Roma
Site status: Not listed — confirm with the team
Local Institution
Roma
Site status: Not listed — confirm with the team
Local Institution
Sant'Arsenio (Salerno)
Site status: Not listed — confirm with the team
Poland · 6 sites
Local Institution
Choroszcz
Site status: Not listed — confirm with the team
Local Institution
Gdansk
Site status: Not listed — confirm with the team
Local Institution
Krakow
Site status: Not listed — confirm with the team
Local Institution
Krakow
Site status: Not listed — confirm with the team
Local Institution
Poznan
Site status: Not listed — confirm with the team
Local Institution
Swiecie N/Wisla
Site status: Not listed — confirm with the team
Romania · 3 sites
Local Institution
Bucharest
Site status: Not listed — confirm with the team
Local Institution
Cluj-Nappoca
Site status: Not listed — confirm with the team
Local Institution
Iași
Site status: Not listed — confirm with the team
Russia · 8 sites
Local Institution
Khot'kovo
Site status: Not listed — confirm with the team
Local Institution
Krasnodar
Site status: Not listed — confirm with the team
Local Institution
Moscow
Site status: Not listed — confirm with the team
Local Institution
Moscow
Site status: Not listed — confirm with the team
Local Institution
Rostov-on-Don
Site status: Not listed — confirm with the team
Local Institution
Saint Petersburg
Site status: Not listed — confirm with the team
Local Institution
Samara
Site status: Not listed — confirm with the team
Local Institution
Tomsk
Site status: Not listed — confirm with the team
South Africa · 5 sites
Local Institution
Johannesburg, Gauteng
Site status: Not listed — confirm with the team
Local Institution
Soweto, Gauteng
Site status: Not listed — confirm with the team
Local Institution
Vereeniging, Gauteng
Site status: Not listed — confirm with the team
Local Institution
Pinetown, KwaZulu-Natal
Site status: Not listed — confirm with the team
Local Institution
Cape Town, Western Cape
Site status: Not listed — confirm with the team
Spain · 3 sites
Local Institution
Barcelona
Site status: Not listed — confirm with the team
Local Institution
Madrid
Site status: Not listed — confirm with the team
Local Institution
Murcia
Site status: Not listed — confirm with the team
Türkiye · 3 sites
Local Institution
Ankara
Site status: Not listed — confirm with the team
Local Institution
Antalya
Site status: Not listed — confirm with the team
Local Institution
Denizli
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Aripiprazole, Placebo, Lithium, Valproate. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: Over 18 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.otsuka.co.jp/en/. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.